Keywords Starting With the Letter S

satralizumab linker

semaglutide intermediate

Semaglutide side chain

semaglutude intermediate

sensitive drug (R)-Azetidine-2-carboxylic acid

sensitive drug (S)-N-Fmoc-azetidine-2-carboxylic acid

sensitive drug 1-Boc-3-Aminoazetidine

sensitive drug 1-Boc-azetidine-3-ylmethanol

sensitive drug Fmoc-L-Azetidine-3-carboxylic acid

sequence-specific DMT-dA(Bz)-CE Reverse Phosphoramidite

sequence-specific DMT-dG(iBu)-CE-Phosphoramidite

sequence-specific human diseases DMT-dA(Bz)-CE Reverse Phosphoramidite yellow powder

sequence-specific human diseases DMT-dG(iBu)-CE-Phosphoramidite

sequence-specific human diseases N2-iBu-DMT-dG2

sequence-specific N2-iBu-DMT-dG2

short

short chidlren

sicochemical (S)-2-(32-azido-5-oxo-3 9 12 15 18 21 24 27 30-nonaoxa-6-azadot

sicochemical 1 4-DIAMINOBUTANE

sicochemical synthesis (S)-2-(32-azido-5-oxo-3 9 12 15 18 21 24 27 30-nonaoxa-6-azadot

sicochemical synthesis 1 4-DIAMINOBUTANE

Side chain library

site-specific clinical trials MC-GGFG-Glycolic acid

site-specific MC-GGFG-Glycolic acid

Small molecule compounds

Small molecule compounds-

Small moleculer Fmoc-PEG6-propionic Acid

SNAC

solid 1 8-Diamino-3 6-dioxaoctane

solid 12-AMINODODECANOIC ACID

solid 2-[2-(2-AMINOETHOXY)ETHOXY]ETHANOL

solid 22-(tert-butoxy)-22-oxodocosanoic acid

solid 4 7 10-TRIOXA-1 13-TRIDECANEDIAMINE

solid 6-Maleimidocaproic acid

solid Amino-PEG4-Amine

solid api SNAC

solid biological DMT-dG(dmf)-CE Reverse Phosphoramidite

solid biological DMT-dT-CE-Phosphoramidite

solid biological DMT-PEG5 Phosphoramidite

solid biological N6-dma-DMT-dA

solid biological N6-Me-DMT-dA-CE Phosphoramidite

solid BOC-PEG36-CH2CH2COOH

solid C10 diacid + εLys + C10 diacid + γGlu

solid chemistry 1 8-Diamino-3 6-dioxaoctane

solid chemistry Amino-PEG4-Amine

solid Cis-4-Hydroxy-D-proline Hydrochloride

solid custom 6-Maleimidocaproic acid

solid customized DOTA-MIPA

solid customized HO-PEG3-CH2COOH

solid DMT-dG(dmf)-CE Reverse Phosphoramidite

solid DMT-dT-CE-Phosphoramidite

solid DMT-PEG5 Phosphoramidite

solid DOTA-MIPA

solid Fmoc-Hyp（Bom）-OH

solid Fmoc-Lys-(Pal-Glu-OtBu)-OH

Solid FMoc-NH-PEG4-CH2CH2COOH

solid for breast cancer 6-Maleimidocaproic acid

solid Hexadecanedioic acid- mono(1-1-dimethylethyl) ester

solid high purity 2-[2-(2-AMINOETHOXY)ETHOXY]ETHANOL

solid high purity 4 7 10-TRIOXA-1 13-TRIDECANEDIAMINE

solid HO-PEG3-CH2COOH

solid medical intermediate DOTA-MIPA

solid medical intermediate HO-PEG3-CH2COOH

solid N6-dma-DMT-dA

solid N6-Me-DMT-dA-CE Phosphoramidite

solid pharmaceutical intermediates DMT-dG(dmf)-CE Reverse Phosphoramidite

solid pharmaceutical intermediates DMT-dT-CE-Phosphoramidite

solid pharmaceutical intermediates DMT-PEG5 Phosphoramidite

solid pharmaceutical intermediates N6-dma-DMT-dA

solid pharmaceutical intermediates N6-Me-DMT-dA-CE Phosphoramidite

solid proteolysis-targeting 1 8-Diamino-3 6-dioxaoctane

solid proteolysis-targeting Amino-PEG4-Amine

solid SNAC

solid supplement Cis-4-Hydroxy-D-proline Hydrochloride

solid supplement Fmoc-Hyp（Bom）-OH

solid supplement Trans-4-Hydroxy-D-proline

solid supplement Trans-4-Hydroxy-L-proline Methyl Ester Hydrochloride

Solid T-boc-N-amido-dPEG12-acid

solid Trans-4-Hydroxy-D-proline

solid Trans-4-Hydroxy-L-proline Methyl Ester Hydrochloride

solid treatments 2-[2-(2-AMINOETHOXY)ETHOXY]ETHANOL

solid treatments 4 7 10-TRIOXA-1 13-TRIDECANEDIAMINE

soluble (2R 4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1 2-dicarboxyla

soluble (2S 4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic

soluble biotechnological (2R 4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1 2-dicarboxyla

soluble biotechnological (2S 4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic

soluble biotechnological N-Boc-cis-4-Hydroxy-L-proline methyl ester

soluble cosmetics methyl cis-1-boc-4-hydroxy-d-prolinate

soluble cosmetics N-Boc-trans-4-Hydroxy-L-proline methyl ester

soluble Methyl (2S 4S)-4-hydroxypyrrolidine-2-carboxylate hydrochloride

soluble methyl cis-1-boc-4-hydroxy-d-prolinate

soluble N-Boc-trans-4-Hydroxy-L-proline methyl ester

solublel N-Boc-cis-4-Hydroxy-L-proline methyl ester

solution (2R 4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1 2-dicarboxyla

solution (2S 4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic

solution 4-(N-(16-(1H-tetrazol-5-yl)hexadecanoyl)sulfamoyl)butanoic acid

solution biotechnological (2R 4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1 2-dicarboxyl

solution biotechnological (2S 4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic

solution biotechnological N-Boc-cis-4-Hydroxy-L-proline methyl ester

solution C16-OtBu-Glu-OtBu

solution C20-OtBu-Glu(OtBu)-AEEA-AEEA-OH

Solution Cbz-N-amido-PEG6-acid

solution FMOC-LYS-OH HCL

solution M-dPEG4-NHS Ester

solution N-Boc-cis-4-Hydroxy-L-proline methyl ester

solution soluble (2R 4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1 2-dicarboxyla

solution soluble (2S 4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic

solution soluble N-Boc-cis-4-Hydroxy-L-proline methyl ester

solvent Biotin-PEG11-Azide

Somapacitan

Spacers 98% Boc-AEEA

Spacers 98% Boc-NH-PEG1-CH2COOH

Spacers 98% Boc-NH-PEG23-CH2CH2NH2

Spacers 98% Boc-NH-PEG3-CH2CH2COOH

Spacers 98% Boc-NH-PEG5-CH2COOH

Spacers Boc-AEEA

Spacers Boc-NH-PEG1-CH2COOH

Spacers Boc-NH-PEG23-CH2CH2NH2

Spacers Boc-NH-PEG3-CH2CH2COOH

Spacers Boc-NH-PEG5-CH2COOH

Spacers heterobifunctional Boc-AEEA

Spacers heterobifunctional Boc-NH-PEG1-CH2COOH

Spacers heterobifunctional Boc-NH-PEG23-CH2CH2NH2

Spacers heterobifunctional Boc-NH-PEG3-CH2CH2COOH

Spacers heterobifunctional Boc-NH-PEG5-CH2COOH

Specific M-dPEG2-NHS Ester

Specific M-dPEG8-NHS Ester

spray (R)-Azetidine-2-carboxylic acid

spray 1-Benzyl 3-methyl azetidine-1 3-dicarboxylate

spray 1-Fmoc-3-hydroxyazetidine

spray 3-Azetidinecarboxylic acid

spray Benzyl 3-hydroxyazetidine-1-carboxylate

stability MC-GGFG-Glycolic acid

stability medical intermediate MC-GGFG-Glycolic acid

stability medical intermediate Satralizumab Linker

stability medical intermediate Val-Cit-PAB

stability Satralizumab Linker

stability Val-Cit-PAB

stable 22-(tert-butoxy)-22-oxodocosanoic acid

stable 98% Ste-Glu-AEEA-AEEA-OSU

stable 98% TBuO-Ste-Glu(OtBu)-OH

Stable 99% Cbz-N-amido-PEG12-acid

stable biology DMT-dA(dma)-CE-Phosphoramidite

stable biology N2-dmf-DMT-dG

stable C16-OtBu-Glu-OtBu

Stable Cbz-N-amido-PEG12-acid

stable DMT-dA(dma)-CE-Phosphoramidite

stable N2-dmf-DMT-dG

stable NO2A-Azide

stable solid 22-(tert-butoxy)-22-oxodocosanoic acid

stable solution C16-OtBu-Glu-OtBu

stable Ste-Glu-AEEA-AEEA-OSU

stable targeted delivery NO2A-Azide

stable targeted delivery P-NH2-Bn-DOTA

stable targeted P-NH2-Bn-DOTA

stable TBuO-Ste-Glu(OtBu)-OH

stable [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid

supplement Cis-4-Hydroxy-D-proline Hydrochloride

supplement Fmoc-Hyp（Bom）-OH

supplement Trans-4-Hydroxy-D-proline

supplement Trans-4-Hydroxy-L-proline Methyl Ester Hydrochloride

suppressant 99% Pal-Glu(OSU)-OH

suppressant injection grade Pal-Glu(OSU)-OH

suppressant Pal-Glu(OSU)-OH

Surface proteins 98% M-dPEG12-acid

Surface proteins enzymatic M-dPEG12-acid

Surface proteins M-dPEG12-acid

synthesis (S)-2-(32-azido-5-oxo-3 9 12 15 18 21 24 27 30-nonaoxa-6-azadot

synthesis 1 4-DIAMINOBUTANE

synthesis 3 6 9 12 15 18-hexaoxaicosanedioic acid

synthesis crystal HEXADECANEDIOIC ACID

synthesis HEXADECANEDIOIC ACID

synthesis MIPA-NOTA

synthesized 95% TBuO-Ste-Glu(AEEA-AEEA-OH)OtBu

synthesized FMOC-LYS-OH HCL

synthesized lab (S)-4-Hydroxy-D-proline Methyl Ester Hydrochloride

synthesized powder FMOC-LYS-OH HCL

synthesized TBuO-Ste-Glu(AEEA-AEEA-OH)OtBu